GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » KalVista Pharmaceuticals Inc (STU:4XC1) » Definitions » Net Policyholder Benefits/Claims

KalVista Pharmaceuticals (STU:4XC1) Net Policyholder Benefits/Claims


View and export this data going back to 2016. Start your Free Trial

What is KalVista Pharmaceuticals Net Policyholder Benefits/Claims?

Net Policyholder Benefits/Claims only applies to insurance companies.


KalVista Pharmaceuticals (STU:4XC1) Business Description

Traded in Other Exchanges
Address
55 Cambridge Parkway, Suite 901 East, Cambridge, MA, USA, 02142
KalVista Pharmaceuticals Inc is a pharmaceutical company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema and diabetic macular edema; and oral plasma kallikrein inhibitors. Geographically it operates throughout the region of the United States.